Tasso is a Biotech company based in Seattle. It has raised $120M in total funding. Latest round: Series B.
Tasso funding overview
Tasso is a Biotech company based in Seattle. Tasso has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2021. The round record for Tasso runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, D.E. Shaw Group, Senvest, InCube, SVB Innovation Fund, Foresite Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
Tasso at a glance
Total raised
$120M
Latest round
Series B
Latest round date
December 2021
Industry
Biotech
Headquarters
Seattle
Notable investors
RA Capital Management, D.E. Shaw Group, Senvest, InCube, SVB Innovation Fund, Foresite Capital, Hambrecht Ducera Growth Ventures, J2V
Frequently asked about Tasso funding
How much has Tasso raised?
Tasso has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Tasso?
RA Capital Management, D.E. Shaw Group, Senvest, InCube, SVB Innovation Fund, Foresite Capital are named among the investors backing Tasso.
What was the latest Tasso funding round?
The most recent disclosed round is a Series B, announced in December 2021.
Where is Tasso based?
Tasso is based in Seattle.
What sector does Tasso operate in?
Tasso is tracked under Biotech from Seattle, with $120M in disclosed funding.
When did Tasso last raise?
The last disclosed Tasso round closed in December 2021 at Series B.
Totals shown for Tasso aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Seattle and the investors behind them below.
